Robert F Kushner

27PUBLICATIONS
120CO-AUTHORS
Predictive and prognostic markersMedicine, nursing and health curriculum and pedagogyPharmacogenomicsSocial and personality psychology not elsewhere classifiedWastewater treatment processes
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jun 18, 2026
Identifying Predictors of Weight-Related Outcomes With Fixed-Dose, Extended-Release Naltrexone and Bupropion Among Treatment-Adherent Patients in Phase 3 COR Trials: A Treatment Target Analysis.

|May 25, 2026
Uncovering Gaps in Obesity Medicine Competencies: Insights from Ten U.S. Medical Schools.

|Mar 31, 2026
Use of Naltrexone-Bupropion in Persons With Overweight/Obesity and Symptoms of Depression: A Pooled Analysis.

Jena Shaw Tronieri, Robert F Kushner, Caroline M Apovian

|Jan 15, 2026
Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT.

Thomas A Wadden, Maria A Oquendo, Robert F Kushner

|Nov 13, 2025
Correction: Quality of life improvements associated with weight loss using a novel shape-shifting hydrogel capsule: RESET study results.

Robert F Kushner, Jamy D Ard, Thomas A Wadden

|Sep 16, 2025
Quality of life improvements associated with weight loss using a novel shape-shifting hydrogel capsule: RESET study results.

Robert F Kushner, Jamy D Ard, Thomas A Wadden

Pageof 5

Frequent Collaborators

8 joint publications

Thomas Wadden

4 joint publications

Ildiko Lingvay

3 joint publications

John M Jakicic

3 joint publications

Frank L Greenway